Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.58NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.631NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.627NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.519NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.514NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.87NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAPNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.47.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DJ.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BW.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FW.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.422NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.198NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.366NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20237.1US
B.1.441NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.416NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.263NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.135NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.219NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.208NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used